Filtered By:
Drug: Dexamethasone

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 6433 results found since Jan 2013.

Cancers, Vol. 10, Pages 492: Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?
nin To date, no targeted drugs, antibodies or combinations of chemotherapeutics have been demonstrated to be more efficient than temozolomide, or to increase efficacy of standard therapy (surgery, radiotherapy, temozolomide, steroid dexamethasone). According to recent phase III trials, standard therapy may ensure a median overall survival of up to 18–20 months for adult patients with newly diagnosed glioblastoma. These data explain a failure of positive non-controlled phase II trials to predict positive phase III trials and should result in revision of the landmark Stupp trial as a historical control for ...
Source: Cancers - December 5, 2018 Category: Cancer & Oncology Authors: Aleksei A. Stepanenko Vladimir P. Chekhonin Tags: Review Source Type: research

Pulmonary arterial hypertension in a patient with multiple myeloma during carfilzomib treatment: in search of better management.
CONCLUSION: The mechanism responsible for cardiac and vascular events during carfilzomib therapy is unclear. This case report highlights that it is important to define at baseline the appropriate screening of patients undergoing carfilzomib therapy with specific monitoring and symptom management and that future large prospective controlled studies are needed to define the correct monitoring strategy in refractory and relapsed multiple myeloma and the potential mechanism of vascular events. PMID: 33525991 [PubMed - as supplied by publisher]
Source: Tumori - February 4, 2021 Category: Cancer & Oncology Tags: Tumori Source Type: research

Resistance training prevents the reduction of insulin-mediated vasodilation in the mesenteric artery of dexamethasone-treated rats.
This study evaluated whether resistance training (RT) could prevent glucocorticoid-induced vascular changes. Wistar rats were divided into groups: control (CO), dexamethasone (DEX), and Dexamethasone+RT (DEX+RT). On the eighth week, dexamethasone was administered in the DEX and DEX+RT groups. Thereafter, the animals were sacrificed and blood samples were used to assess the lipid profile, glucose and insulin. Vascular reactivity to insulin and phenylephrine (Phe) were evaluated. The DEX+RT group presented an improvement in the lipid profile, fasting glucose, and insulin levels compared to the DEX group. In addition, vasodil...
Source: An Acad Bras Cienc - December 19, 2020 Category: Science Authors: Araujo JES, Macedo FN, Oliveira DPM, Britto RM, Quintans JSS, Barreto RSS, Santos MRV, Quintans-Junior LJ, Barreto AS Tags: An Acad Bras Cienc Source Type: research

Interventions for focal segmental glomerulosclerosis in adults
CONCLUSIONS: No RCTs, which evaluated corticosteroids, were identified although the KDIGO guidelines recommend corticosteroids as the first treatment for adults with FSGS. The studies identified included participants with steroid-resistant FSGS. Treatment with cyclosporin for at least six months was more likely to achieve complete remission of proteinuria compared with other treatments but there was considerable imprecision due to few studies and small participant numbers. In future studies of existing or new interventions, the investigators must clearly define the populations included in the study to provide appropriate r...
Source: Cochrane Database of Systematic Reviews - February 28, 2022 Category: General Medicine Authors: Elisabeth M Hodson Aditi Sinha Tess E Cooper Source Type: research

Efficacy of COVID-19 treatments among geriatric patients: a systematic review
CONCLUSION: No agent is known to be effective for preventing COVID-19 after exposure to the virus. Further research is needed to ensure safety and efficacy of each of the reviewed interventions for older adults.PMID:35677110 | PMC:PMC9168946 | DOI:10.1177/20499361221095666
Source: Adv Data - June 9, 2022 Category: Epidemiology Authors: Helen Senderovich Danusha Vinoraj Madeline Stever Sarah Waicus Source Type: research

Corticosteroids for the management of cancer-related fatigue in adults with advanced cancer
CONCLUSIONS: There is insufficient evidence to support or refute the use of systemic corticosteroids in adults with cancer and CRF. We included four small studies that provided very low-certainty of evidence for the efficacy of corticosteroids in the management of CRF. Further high-quality randomised controlled trials with larger sample sizes are required to determine the effectiveness of corticosteroids in this setting.PMID:36688471 | PMC:PMC9869433 | DOI:10.1002/14651858.CD013782.pub2
Source: Cochrane Database of Systematic Reviews - January 23, 2023 Category: General Medicine Authors: Amy Sandford Alison Haywood Kirsty Rickett Phillip Good Sohil Khan Karyn Foster Janet R Hardy Source Type: research

Intratympanic corticosteroids for M énière's disease
CONCLUSIONS: The evidence for intratympanic corticosteroids in the treatment of Ménière's disease is uncertain. There are relatively few published RCTs, which all consider the same type of corticosteroid (dexamethasone). We also have concerns about publication bias in this area, with the identification of two large RCTs that remain unpublished. The evidence comparing intratympanic corticosteroids to placebo or no treatment is therefore all low- or very low-certainty. This means that we have very low confidence that the effects reported are accurate estimates of the true effect of these interventions. Consensus on the app...
Source: Cochrane Database of Systematic Reviews - February 27, 2023 Category: General Medicine Authors: Katie E Webster Ambrose Lee Kevin Galbraith Natasha A Harrington-Benton Owen Judd Diego Kaski Otto R Maarsingh Samuel MacKeith Jaydip Ray Vincent A Van Vugt Brian Westerberg Martin J Burton Source Type: research

National Utilization and Forecasting of Ototopical Antibiotics: Medicaid Data Versus “Dr. Google”
Objectives: To forecast national Medicaid prescription volumes for common ototopical antibiotics, and correlate prescription volumes with internet user search interest using Google Trends (GT). Study Design: National United States Medicaid prescription and GT user search database analysis. Methods: Quarterly national Medicaid summary drug utilization data and weekly GT search engine data for ciprofloxacin-dexamethasone (CD), ofloxacin (OF), and Cortisporin (CS) ototopicals were obtained from January 2008 to July 2014. Time series analysis was used to assess prescription seasonality, Holt–Winter's method for forecasting...
Source: Otology and Neurotology - August 13, 2016 Category: ENT & OMF Tags: Middle Ear and Mastoid Disease Source Type: research

Potential Dexamethasone-Direct Oral Anticoagulant Drug Interaction: Is This a Concern in COVID?
CONCLUSIONS: Concurrent use of dexamethasone and apixaban or rivaroxaban in hospitalized COVID-19 patients with laboratory evidence of COVID coagulopathy should be avoided until higher-quality data are available.PMID:34137279 | DOI:10.1177/10600280211025042
Source: The Annals of Pharmacotherapy - June 17, 2021 Category: Drugs & Pharmacology Authors: Maureen A Smythe Carly Burns Qianyue Liu Candice L Garwood Source Type: research

Systemic corticosteroids for the treatment of COVID-19
CONCLUSIONS: Moderate-certainty evidence shows that systemic corticosteroids probably slightly reduce all-cause mortality in people hospitalised because of symptomatic COVID-19. Low-certainty evidence suggests that there may also be a reduction in ventilator-free days. Since we are unable to adjust for the impact of early death on subsequent endpoints, the findings for ventilation outcomes and harms have limited applicability to inform treatment decisions. Currently, there is no evidence for asymptomatic or mild disease (non-hospitalised participants). There is an urgent need for good-quality evidence for specific subgroup...
Source: Cochrane Database of Systematic Reviews - August 16, 2021 Category: General Medicine Authors: Carina Wagner Mirko Griesel Agata Mikolajewska Anika Mueller Monika Nothacker Karoline Kley Maria-Inti Metzendorf Anna-Lena Fischer Marco Kopp Miriam Stegemann Nicole Skoetz Falk Fichtner Source Type: research

Pharmacotherapy for SARS-CoV-2 and Seizures for drug repurposing presumed on Mechanistic Targets
CONCLUSION: These findings would hopefully provide the basis for initiating further studies on the pathogenesis and drug targeting strategies for this emerging infection accompanied with seizures or in people with epilepsy.PMID:34645381 | DOI:10.2174/1874467214666211013122528
Source: Epilepsy Curr - October 14, 2021 Category: Neurology Authors: Divya Goel Ankit Srivastava Ángel Aledo-Serrano Anuja Krishnan Divya Vohora Source Type: research